Tirofiban Hydrochloride Hydrate

盐酸替罗非班

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameTirofiban Hydrochloride Hydrate
Drug Alias Name盐酸替罗非班水合物Tirofiban HCl替罗非班TirofibanTirofiban hydrochloride +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsIschemic StrokeThrombosisVascular Diseases +[12
Global Approved IndicationsThrombosisMyocardial InfarctionCoronary Thrombosis +[5
Approved Indications in ChinaMyocardial InfarctionAngina, Unstable
Original Approved Country/TerritoryUnited States
Original Approved Date1998/05/14
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesThe University Of Iowa
Active IndicationsIschemic StrokeThrombosisVascular Diseases +[10
Inactive IndicationsCardiovascular DiseasesRenal Insufficiency

Other Information

ATC CodeB01AC17